Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01680692 · ClinicalTrials.gov registry record · Early Phase 1
Continuous Femoral and Tibial Nerve Blocks in TKA Patients
A Early Phase 1 study, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 2
- Enrollment target
NCT01680692 is a Early Phase 1 study that was terminated before completion, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 2 participants.
The verdict
NCT01680692, a Early Phase 1 study, was terminated before completion, sponsored by Texas Tech University Health Sciences Center, El Paso.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether a new regional anesthesia technique would provide better pain control, patient satisfaction, less narcotic use and no symptoms of foot drop after knee replacement surgery.
Interventions
- DRUG Ropivicaine
- DEVICE Continuous Femoral Nerve Catheter
- DEVICE Continuous Tibial Nerve Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01680692
The ClinicalTrials.gov registry entry for NCT01680692 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, El Paso, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ropivicaine is the first listed.
NCT01680692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01680692 about?
NCT01680692 is a clinical study titled "Continuous Femoral and Tibial Nerve Blocks in TKA Patients". The purpose of this study is to evaluate whether a new regional anesthesia technique would provide better pain control, patient satisfaction, less narcotic use and no symptoms of foot drop after knee replacement surgery.
What is the current status of trial NCT01680692?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 2 participants. The study started on 2012-08. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01680692?
The interventions under investigation include: Ropivicaine (DRUG), Continuous Femoral Nerve Catheter (DEVICE), Continuous Tibial Nerve Catheter (DEVICE).
Who is sponsoring clinical trial NCT01680692?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.